323 related articles for article (PubMed ID: 21444677)
21. MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1.
Ma N; Chen F; Shen SL; Chen W; Chen LZ; Su Q; Zhang LJ; Bi J; Zeng WT; Li W; Huang XH; Wang Q
Biochem Biophys Res Commun; 2015 Jun; 461(4):618-23. PubMed ID: 25912876
[TBL] [Abstract][Full Text] [Related]
22. miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype.
Wang HJ; Guo YQ; Tan G; Dong L; Cheng L; Li KJ; Wang ZY; Luo HF
J Cell Biochem; 2013 Oct; 114(10):2248-57. PubMed ID: 23606360
[TBL] [Abstract][Full Text] [Related]
23. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
24. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.
Liang L; Wong CM; Ying Q; Fan DN; Huang S; Ding J; Yao J; Yan M; Li J; Yao M; Ng IO; He X
Hepatology; 2010 Nov; 52(5):1731-40. PubMed ID: 20827722
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
[TBL] [Abstract][Full Text] [Related]
27. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
Gong J; Zhang JP; Li B; Zeng C; You K; Chen MX; Yuan Y; Zhuang SM
Oncogene; 2013 Jun; 32(25):3071-9. PubMed ID: 22824797
[TBL] [Abstract][Full Text] [Related]
30. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
31. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
32. miR-126 functions as a tumour suppressor in human gastric cancer.
Feng R; Chen X; Yu Y; Su L; Yu B; Li J; Cai Q; Yan M; Liu B; Zhu Z
Cancer Lett; 2010 Dec; 298(1):50-63. PubMed ID: 20619534
[TBL] [Abstract][Full Text] [Related]
33. PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b.
Luo S; Wang J; Ma Y; Yao Z; Pan H
Biochem Biophys Res Commun; 2015 Jun; 462(2):85-90. PubMed ID: 25944662
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.
Liu XX; Li XJ; Zhang B; Liang YJ; Zhou CX; Cao DX; He M; Chen GQ; He JR; Zhao Q
FEBS Lett; 2011 May; 585(9):1363-7. PubMed ID: 21510944
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.
Bockmeyer CL; Christgen M; Müller M; Fischer S; Ahrens P; Länger F; Kreipe H; Lehmann U
Breast Cancer Res Treat; 2011 Dec; 130(3):735-45. PubMed ID: 21409395
[TBL] [Abstract][Full Text] [Related]
36. Development of microRNA-145 for therapeutic application in breast cancer.
Kim SJ; Oh JS; Shin JY; Lee KD; Sung KW; Nam SJ; Chun KH
J Control Release; 2011 Nov; 155(3):427-34. PubMed ID: 21723890
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.
Schunke D; Span P; Ronneburg H; Dittmer A; Vetter M; Holzhausen HJ; Kantelhardt E; Krenkel S; Müller V; Sweep FC; Thomssen C; Dittmer J
Cancer Res; 2007 Nov; 67(22):10694-702. PubMed ID: 18006811
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of miR-146a in gastric cancer cases.
Kogo R; Mimori K; Tanaka F; Komune S; Mori M
Clin Cancer Res; 2011 Jul; 17(13):4277-84. PubMed ID: 21632853
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA miR-125b induces senescence in human melanoma cells.
Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
[TBL] [Abstract][Full Text] [Related]
40. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
